Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Published online before print September 30, 2009
(Neurology 2009, doi:10.1212/WNL.0b013e3181beecd3)
This Article
Right arrow Full Text (Rapid PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Annweiler, C.
Right arrow Articles by Beauchet, O.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Annweiler, C.
Right arrow Articles by Beauchet, O.
Related Collections
Right arrow Endocrine
Right arrow Neuropsychological assessment
Right arrow Cognitive aging
Right arrow Cohort studies
Received March 5, 2009
Accepted August 12, 2009

Association of vitamin D deficiency with cognitive impairment in older women. Cross-sectional study

C. Annweiler MD, MS*, A. M. Schott MD, PhD, G. Allali MD, PhD, S. A. Bridenbaugh MD, R. W. Kressig MD, P. Allain PhD, F. R. Herrmann MD, MPH, and O. Beauchet MD, PhD

From the Department of Internal Medicine and Geriatrics (C.A., O.B.) and Neuropsychological Unit, Department of Neurology (P.A.), Angers University Hospital; UPRES EA 2646, University of Angers, UNAM, France; Department of Medical Information (A.M.S.), Lyon University Hospital, France; Departments of Neurology (G.A.) and of Rehabilitation and Geriatrics (F.R.H.), Geneva University Hospitals and University of Geneva, Switzerland; and Department of Acute Geriatrics (S.A.B., R.W.K.), Basel University Hospital and University of Basel, Switzerland.


* To whom correspondence should be addressed. E-mail: ceannweiler{at}chu-angers.fr.

Objective: The association between low serum 25-hydroxyvitamin D [25(OH)D] concentration and cognitive decline has been investigated by only a few studies, with mixed results. The objective of this cross-sectional population-based study was to examine the association between serum 25(OH)D deficiency and cognitive impairment while taking confounders into account.

Methods: The subjects, 752 women aged ≥75 years from the Epidémiologie de l'Ostéoporose (EPIDOS) cohort, were divided into 2 groups according to serum 25(OH)D concentrations (either deficient, <10 ng/mL, or nondeficient, ≥10 ng/mL). Cognitive impairment was defined as a Pfeiffer Short Portable Mental State Questionnaire (SPMSQ) score <8. Age, body mass index, number of chronic diseases, hypertension, depression, use of psychoactive drugs, education level, regular physical activity, and serum intact parathyroid hormone and calcium were used as potential confounders.

Results: Compared with women with serum 25(OH)D concentrations ≥10 ng/mL (n = 623), the women with 25(OH)D deficiency (n = 129) had a lower mean SPMSQ score (p < 0.001) and more often had an SPMSQ score <8 (p = 0.006). There was no significant linear association between serum 25(OH)D concentration and SPMSQ score ({beta} = -0.003, 95% confidence interval -0.012 to 0.006, p = 0.512). However, serum 25(OH)D deficiency was associated with cognitive impairment (crude odds ratio [OR] = 2.08 with p = 0.007; adjusted OR = 1.99 with p = 0.017 for full model; and adjusted OR = 2.03 with p = 0.012 for stepwise backward model).

Conclusions: 25-Hydroxyvitamin D deficiency was associated with cognitive impairment in this cohort of community-dwelling older women.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2009 by AAN Enterprises, Inc.